Similar articles for PMID: 20231949

Year	Number of Results
1945	1
1957	1
1959	2
1960	3
1961	6
1962	4
1963	2
1964	2
1965	4
1968	1
1971	1
1972	1
1973	1
1974	1
1975	2
1976	1
1977	1
1978	1
1981	1
1982	1
1983	4
1984	6
1985	3
1988	2
1989	2
1990	1
1991	8
1992	6
1993	3
1994	2
1995	13
1996	11
1997	5
1998	11
1999	12
2000	11
2001	11
2002	9
2003	9
2004	9
2005	11
2006	7
2007	9
2008	9
2009	7
2010	8
2011	12
2012	12
2013	15
2014	13
2015	14
2016	15
2017	12
2018	15
2019	17
2020	16
2021	12
2022	6
2023	6
2024	0

1

Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.

Al-Mendalawi MD, Abdul-Wahab A, Janahi IA, Abdel-Rahman MO. Al-Mendalawi MD, et al. Saudi Med J. 2010 Mar;31(3):339-40; author reply 340. Saudi Med J. 2010. PMID: 20231949 No abstract available.

2

Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation.

Abdul-Wahab A, Janahi IA, Abdel-Rahman MO. Abdul-Wahab A, et al. Saudi Med J. 2009 Aug;30(8):1101-2. Saudi Med J. 2009. PMID: 19668897 No abstract available.

3

Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.

Soultan ZN, Foster MM, Newman NB, Anbar RD. Soultan ZN, et al. J Pediatr. 2008 Dec;153(6):857-9. doi: 10.1016/j.jpeds.2008.07.054. J Pediatr. 2008. PMID: 19014821

4

Mutations of the cystic fibrosis gene and pancreatitis.

Ren CL. Ren CL. N Engl J Med. 1999 Jan 21;340(3):238-9. doi: 10.1056/NEJM199901213400316. N Engl J Med. 1999. PMID: 9917235 No abstract available.

5

Screening for cystic fibrosis: the importance of using the correct tools.

Shah U, Moatter T. Shah U, et al. J Ayub Med Coll Abbottabad. 2006 Jan-Mar;18(1):7-10. J Ayub Med Coll Abbottabad. 2006. PMID: 16773960 Clinical Trial.

6

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.

Goubau C, Wilschanski M, Skalická V, Lebecque P, Southern KW, Sermet I, Munck A, Derichs N, Middleton PG, Hjelte L, Padoan R, Vasar M, De Boeck K. Goubau C, et al. Thorax. 2009 Aug;64(8):683-91. doi: 10.1136/thx.2008.104752. Epub 2009 Mar 23. Thorax. 2009. PMID: 19318346

7

Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.

Keiles S, Koepke R, Parad R, Kharrazi M; California Cystic Fibrosis Newborn Screening Consortium. Keiles S, et al. J Cyst Fibros. 2012 May;11(3):257-60. doi: 10.1016/j.jcf.2011.11.010. Epub 2011 Dec 30. J Cyst Fibros. 2012. PMID: 22209734 Free article.

8

When to suspect atypical cystic fibrosis.

Chawla A, Turcotte FG, Usmani K, Kanu AC. Chawla A, et al. J Fam Pract. 2010 Sep;59(9):509-13. J Fam Pract. 2010. PMID: 20824227

9

Cystic fibrosis.

Rowe SM, Miller S, Sorscher EJ. Rowe SM, et al. N Engl J Med. 2005 May 12;352(19):1992-2001. doi: 10.1056/NEJMra043184. N Engl J Med. 2005. PMID: 15888700 No abstract available.

10

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.

Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Wilschanski M, et al. J Pediatr. 1995 Nov;127(5):705-10. doi: 10.1016/s0022-3476(95)70157-5. J Pediatr. 1995. PMID: 7472820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

360 results

Results by year